LIANBIO-ADR (LIAN) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:LIAN • US53000N1081

0.319 USD
-0.03 (-8.28%)
At close: Mar 18, 2024
0.32 USD
+0 (+0.31%)
After Hours: 3/18/2024, 8:21:48 PM
Fundamental Rating

3

LIAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. LIAN has a great financial health rating, but its profitability evaluates not so good. LIAN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year LIAN has reported negative net income.
  • LIAN had a negative operating cash flow in the past year.
LIAN Yearly Net Income VS EBIT VS OCF VS FCFLIAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M

1.2 Ratios

  • With a decent Return On Assets value of -33.47%, LIAN is doing good in the industry, outperforming 68.54% of the companies in the same industry.
  • LIAN's Return On Equity of -43.49% is fine compared to the rest of the industry. LIAN outperforms 71.77% of its industry peers.
Industry RankSector Rank
ROA -33.47%
ROE -43.49%
ROIC N/A
ROA(3y)-43.5%
ROA(5y)N/A
ROE(3y)-54.1%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIAN Yearly ROA, ROE, ROICLIAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for LIAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIAN Yearly Profit, Operating, Gross MarginsLIAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, LIAN has less shares outstanding
  • There is no outstanding debt for LIAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LIAN Yearly Shares OutstandingLIAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
LIAN Yearly Total Debt VS Total AssetsLIAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

  • LIAN has an Altman-Z score of -2.81. This is a bad value and indicates that LIAN is not financially healthy and even has some risk of bankruptcy.
  • LIAN has a Altman-Z score of -2.81. This is comparable to the rest of the industry: LIAN outperforms 44.73% of its industry peers.
  • There is no outstanding debt for LIAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.81
ROIC/WACCN/A
WACCN/A
LIAN Yearly LT Debt VS Equity VS FCFLIAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

  • LIAN has a Current Ratio of 10.07. This indicates that LIAN is financially healthy and has no problem in meeting its short term obligations.
  • LIAN has a better Current ratio (10.07) than 78.40% of its industry peers.
  • LIAN has a Quick Ratio of 10.07. This indicates that LIAN is financially healthy and has no problem in meeting its short term obligations.
  • LIAN has a better Quick ratio (10.07) than 78.40% of its industry peers.
Industry RankSector Rank
Current Ratio 10.07
Quick Ratio 10.07
LIAN Yearly Current Assets VS Current LiabilitesLIAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

  • LIAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.32%, which is quite impressive.
EPS 1Y (TTM)28.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 27.35% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LIAN will show a very strong growth in Revenue. The Revenue will grow by 171.95% on average per year.
EPS Next Y16%
EPS Next 2Y7%
EPS Next 3Y16.47%
EPS Next 5Y27.35%
Revenue Next Year-100%
Revenue Next 2Y123.61%
Revenue Next 3Y-25.99%
Revenue Next 5Y171.95%

3.3 Evolution

LIAN Yearly Revenue VS EstimatesLIAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2024 2027 2028 2029 2030 500M 1B 1.5B
LIAN Yearly EPS VS EstimatesLIAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LIAN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LIAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LIAN Price Earnings VS Forward Price EarningsLIAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIAN Per share dataLIAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LIAN's earnings are expected to grow with 16.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7%
EPS Next 3Y16.47%

More info and screens

0

5. Dividend

5.1 Amount

  • LIAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIANBIO-ADR / LIAN FAQ

What is the fundamental rating for LIAN stock?

ChartMill assigns a fundamental rating of 3 / 10 to LIAN.


What is the valuation status for LIAN stock?

ChartMill assigns a valuation rating of 0 / 10 to LIANBIO-ADR (LIAN). This can be considered as Overvalued.


Can you provide the profitability details for LIANBIO-ADR?

LIANBIO-ADR (LIAN) has a profitability rating of 1 / 10.


What is the earnings growth outlook for LIANBIO-ADR?

The Earnings per Share (EPS) of LIANBIO-ADR (LIAN) is expected to grow by 16% in the next year.